Tandem Investment Advisors Inc. Increases Position in The Procter & Gamble Company (NYSE:PG)

Tandem Investment Advisors Inc. lifted its position in shares of The Procter & Gamble Company (NYSE:PG) by 781.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,094 shares of the company’s stock after purchasing an additional 16,041 shares during the period. Tandem Investment Advisors Inc.’s holdings in Procter & Gamble were worth $3,134,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of PG. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at $28,000. Fairway Wealth LLC purchased a new stake in Procter & Gamble during the 2nd quarter valued at approximately $29,000. Ruedi Wealth Management Inc. increased its holdings in shares of Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares during the period. POM Investment Strategies LLC purchased a new position in Procter & Gamble during the 2nd quarter worth $34,000. Finally, Quest Partners LLC acquired a new position in shares of Procter & Gamble during the second quarter worth about $36,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Activity

In related news, insider Susan Street Whaley sold 450 shares of Procter & Gamble stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now directly owns 13,072 shares of the company’s stock, valued at $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Susan Street Whaley sold 450 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the sale, the insider now owns 13,072 shares of the company’s stock, valued at $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 313,597 shares of company stock worth $53,268,499 over the last three months. Corporate insiders own 0.18% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. DA Davidson increased their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday, October 21st. Evercore ISI upped their target price on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Finally, DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a research note on Thursday, August 29th. Nine research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $177.00.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $163.41 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The business’s fifty day moving average price is $171.29 and its two-hundred day moving average price is $168.13. The firm has a market capitalization of $384.84 billion, a PE ratio of 28.17, a P/E/G ratio of 3.57 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s revenue was down .6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.83 earnings per share. On average, research analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.46%. Procter & Gamble’s payout ratio is 69.48%.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.